Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04088071 · ClinicalTrials.gov registry record
Real-world Experience of Catheter Ablation for the Treatment of Paroxysmal and Persistent Atrial Fibrillation
A clinical trial of Paroxysmal Atrial Fibrillation and Persistent Atrial Fibrillation, sponsored by Heart Rhythm Clinical and Research Solutions.
- Recruiting
- Registry status
- 15,000
- Enrollment target
- 20
- Study locations
NCT04088071 is a study of Paroxysmal Atrial Fibrillation and Persistent Atrial Fibrillation that is actively recruiting participants, run by Heart Rhythm Clinical and Research Solutions. The registered enrollment target is 15,000 participants, above the 234-participant average among 24 other Paroxysmal Atrial Fibrillation trials with a reported enrollment target (6310% higher). The trial reports 20 study locations across 7 states.
The verdict
NCT04088071, a study of Paroxysmal Atrial Fibrillation and Persistent Atrial Fibrillation, is actively recruiting participants, sponsored by Heart Rhythm Clinical and Research Solutions.
- RECRUITING
- Registry status
- 15,000 participants
- Enrollment target
- 20
- Study locations
Study Summary
The primary purpose of this registry is to obtain real-world clinical experience of Paroxysmal (PAF) and Persistent (PsAF) Atrial Fibrillation ablation radiofrequency (RF) technologies. Data from the registry will be used to assess clinical outcomes, including procedural efficiency, safety, and long-term, effectiveness of catheter ablation with novel RF technologies in PAF and PsAF patients.
Conditions Studied
Interventions
- DEVICE Catheter ablation
Study Locations (20)
Florida
- Ascension St. Vincent's - Jacksonville
- HCA Florida Mercy Hospital - Miami
- Naples Community Hospital - Naples
- Ascension Sacred Heart - Pensacola
- Sarasota Memorial Hospital - Sarasota
- Baycare Health System - Winter Haven
California
- Keck School of Medicine - Los Angeles
- Santa Barbara Cottage Hospital - Santa Barbara
- Community Memorial Hospital - Ventura
- University HealthCare Alliance - Walnut Creek
Alabama
- University of Alabama at Birmingham - Birmingham
- Grandview Medical Center - Birmingham
- Cardiology Associates of Mobile - Mobile
Colorado
- The Medical Center of Aurora - Aurora
- Colorado Heart and Vascular - Golden
- South Denver Cardiology - Littleton
Georgia
- Piedmont Healthcare - Atlanta
- Memorial Health University Medical Center - Savannah
Arizona
- Valley Heart Rhythm Specialists - Chandler
Arkansas
- Arrhythmia Research Group - Jonesboro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15,000 participants |
| Start Date | 2018-01-01 |
| Est. Completion | 2027-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04088071
The ClinicalTrials.gov registry entry for NCT04088071 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 15,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 234-participant average among 24 other Paroxysmal Atrial Fibrillation trials with a reported enrollment target (6310% higher). The listed sponsor is Heart Rhythm Clinical and Research Solutions, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Paroxysmal Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which Catheter ablation is the first listed.
NCT04088071 reports 20 study locations spanning 7 distinct geographic areas - top geographies include Florida, California, Alabama.
Frequently Asked Questions
What is clinical trial NCT04088071 about?
NCT04088071 is a clinical study titled "Real-world Experience of Catheter Ablation for the Treatment of Paroxysmal and Persistent Atrial Fibrillation". The primary purpose of this registry is to obtain real-world clinical experience of Paroxysmal (PAF) and Persistent (PsAF) Atrial Fibrillation ablation radiofrequency (RF) technologies. Data from the registry will be used to assess clinical outcomes, including procedural efficiency, safety, and long...
What is the current status of trial NCT04088071?
This trial is currently recruiting. The enrollment target is 15,000 participants. The study started on 2018-01-01. Estimated completion is 2027-12-31.
What conditions does trial NCT04088071 study?
This clinical trial studies the following conditions: Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation.
What interventions are being tested in trial NCT04088071?
The interventions under investigation include: Catheter ablation (DEVICE).
Who is sponsoring clinical trial NCT04088071?
This trial is sponsored by Heart Rhythm Clinical and Research Solutions, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04088071 being conducted?
This trial has 20 study locations across Alabama, Arizona, Arkansas, California, Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Paroxysmal Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
ULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation vs Control in Redo Ablation Patients
RECRUITING · NA
-
Determinates of Atrial Tracking and Prevalence of Atrial Fibrillation in the Micra AV2 (DANCE AFIB)
RECRUITING
-
STOP AF First Post-Approval Study
RECRUITING
-
The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.
RECRUITING
-
EXercise Cardiac Magnetic Resonance Assessment of Left Atrial Mechanics Following Ablation
RECRUITING
-
Biomarker-Guided Optimization of Transcutaneous Vagal Stimulation for Atrial (BiG tVNS-AF)
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.